Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05128890 · ClinicalTrials.gov registry record
Evaluation of Resection Techniques for Pancreatic Tumors
A clinical trial of Surgery and Liver Tumor, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 431
- Enrollment target
- 1
- Study location
NCT05128890: Recruiting study of Surgery and Liver Tumor, sponsored by Methodist Health System.
NCT05128890 is a study of Surgery and Liver Tumor that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 431 participants, below the 52,848-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05128890, a study of Surgery and Liver Tumor, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 431 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.
Primary Outcome
It will be calculated in days.Minimally invasive techniques are being adopted for complex pancreatic and liver surgery and there is a need to understand if these techniques are advantageous to the patient, if the cost is justified and if the risks are acceptable when compared to the gold standard open surgery.
Conditions Studied
Interventions
- PROCEDURE Resection techniques for pancreatic and liver tumors
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 431 participants |
| Start Date | 2016-04-16 |
| Est. Completion | 2027-04-26 |
What NCT05128890 shows while recruiting
NCT05128890 is an observational study that tracks outcomes without assigning an intervention. The registered 431 participants enrollment target is mid-sized for trials with a published cap, below the 52,848-participant average among 120 other Surgery trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Resection techniques for pancreatic and liver tumors is the first listed.
NCT05128890 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05128890 about?
NCT05128890 is a clinical study titled "Evaluation of Resection Techniques for Pancreatic Tumors". The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate...
What is the current status of trial NCT05128890?
This trial is currently recruiting. The enrollment target is 431 participants. The study started on 2016-04-16. Estimated completion is 2027-04-26.
What conditions does trial NCT05128890 study?
This clinical trial studies the following conditions: Surgery, Liver Tumor, Pancreas Tumor.
What interventions are being tested in trial NCT05128890?
The interventions under investigation include: Resection techniques for pancreatic and liver tumors (PROCEDURE).
Who is sponsoring clinical trial NCT05128890?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05128890 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05128890's enrollment target sits among peer trials
431 24th of 120 higher than 97 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Terumo Aortic Global Endovascular Registry
RECRUITING
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- NCT05365815 · 432 participants · NA
Melanated Group Midwifery Care (MGMC)
- NCT05499507 · 432 participants · NA
The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
- NCT05806164 · 432 participants · Phase 4
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI